戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 that overexpress a mutated form of the human amyloid-beta precursor protein.
2 rocessing of both the Notch receptor and the amyloid-beta precursor protein.
3 nal cell lines engineered to overexpress the amyloid-beta precursor protein.
4 myloid precursor protein (APP), better named amyloid-beta precursor protein (A(beta)PP), by secretase
5 e core genes were connected to APP (encoding amyloid beta precursor protein), a major player in Alzhe
6 cessing of the familial disease gene product amyloid beta precursor protein (AbetaPP) by beta- and ga
7  brain show alterations in the processing of amyloid beta precursor protein (AbetaPP), including incr
8   Transgenic mice expressing mutant forms of amyloid-beta precursor protein (AbetaPP) and presenilin-
9                             LH did not alter amyloid-beta precursor protein (AbetaPP) expression but
10                                          The amyloid-beta precursor protein (AbetaPP) is a ubiquitous
11  the overexpression of a mutated cDNA of the amyloid-beta precursor protein (AbetaPP) or by knock-in
12  muscle fibers we also studied the effect of amyloid-beta precursor protein (AbetaPP) overexpression
13 orms of Alzheimer's disease (AD) encodes the amyloid-beta precursor protein (AbetaPP) substitution mu
14 ysical interaction of the ER chaperones with amyloid-beta precursor protein (AbetaPP) was studied by
15             We also found no accumulation of amyloid-beta precursor protein after several months of i
16                Intracellular accumulation of amyloid-beta precursor protein, amyloid-beta, and amyloi
17  NCT and PS1 play important roles in binding amyloid beta precursor proteins and modulating PS1 catal
18 se-associated amyloid-beta peptides from the amyloid-beta precursor protein and in releasing the tran
19                Abnormal accumulations of the amyloid-beta precursor protein and of its proteolytic fr
20 ich coexpress mutated human presenilin 1 and amyloid-beta precursor protein) and 30 wild-type mice ag
21 protein expression, that Histone 1 Family 2, amyloid beta precursor protein, and E-cadherin are usefu
22 ntified a caspase-3 cleavage site within the amyloid-beta precursor protein, and a caspase-3 cleavage
23  increased transcription and accumulation of amyloid-beta precursor protein, and accumulation of its
24 a is generated by sequential cleavage of the amyloid beta precursor protein (APP) by beta- and gamma-
25                                 Mutations in amyloid beta precursor protein (APP) gene alter APP proc
26 cts of mutations in the BRI2 (ITM2b) and the amyloid beta precursor protein (APP) genes support the h
27 he familial Alzheimer's disease gene product amyloid beta precursor protein (APP) is sequentially pro
28                       Mice transgenic for an amyloid beta precursor protein (APP) mini-gene driven by
29          All other mutations at this site of amyloid beta precursor protein (APP) reduced C99 generat
30 iP) that catalyzes the final cleavage of the amyloid beta precursor protein (APP) to release the amyl
31  human form of one of these candidate genes, amyloid beta precursor protein (APP), displayed enhanced
32 dependent C-terminal cleavage product of the amyloid beta precursor protein (APP), Fe65, and Tip60, i
33 essed the effects of isoflurane on beta-site amyloid beta precursor protein (APP)-cleaving enzyme (BA
34 nerated by the proteolytic processing of the amyloid beta precursor protein (APP).
35 hen tartrate (Posiphen), lowers secreted (s) amyloid-beta precursor protein (APP) alpha and -beta, am
36 s to a significant decrease in intracellular amyloid-beta precursor protein (APP) and extracellular A
37                Proteolytic processing of the amyloid-beta precursor protein (APP) and generation of a
38 ng number of membrane proteins including the amyloid-beta precursor protein (APP) and Notch.
39 nic (Tg) mice overexpressing mutant forms of amyloid-beta precursor protein (APP) and presenilin 1 (P
40  three Mints bind to the cytoplasmic tail of amyloid-beta precursor protein (APP) and presenilins and
41                      LR11 interacts with the amyloid-beta precursor protein (APP) and regulates APP t
42 al cell cultures secrete exosomes containing amyloid-beta precursor protein (APP) and the APP-process
43                    The transmembrane protein amyloid-beta precursor protein (APP) and the vesicle-ass
44 P-1, which in turn enhances transcription of amyloid-beta precursor protein (APP) and thereby increas
45                           Phosphorylation of amyloid-beta precursor protein (APP) at Thr(668) is a no
46 ghboring cells that express normal levels of amyloid-beta precursor protein (APP) but show redistribu
47                                  Cleavage of amyloid-beta precursor protein (APP) by alpha-,beta-, an
48             Site-specific proteolysis of the amyloid-beta precursor protein (APP) by BACE 1 and gamma
49 stigate the production of Abeta11-40/42 from amyloid-beta precursor protein (APP) by beta-site APP-cl
50                                  Cleavage of amyloid-beta precursor protein (APP) by site-specific pr
51                                              Amyloid-beta precursor protein (APP) forms a transcripti
52                    Although mutations in the amyloid-beta precursor protein (APP) gene are known to c
53                       Abeta is a fragment of amyloid-beta precursor protein (APP) generated in neuron
54 al to the gamma-secretase proteolysis of the amyloid-beta precursor protein (APP) involved in Alzheim
55                  Abnormal phosphorylation of amyloid-beta precursor protein (APP) is a pathologic fea
56                                              Amyloid-beta precursor protein (APP) is well studied for
57 required for the penultimate cleavage of the amyloid-beta precursor protein (APP) leading to the gene
58 5LO did not induce any significant change in amyloid-beta precursor protein (APP) levels and processi
59       As reported in an earlier article, the amyloid-beta precursor protein (APP) region is strongly
60 loidogenic amyloid-beta peptide (Abeta) from amyloid-beta precursor protein (APP) requires cleavage b
61 le in Alzheimer disease, is derived from the amyloid-beta precursor protein (APP) through consecutive
62  and inhibits cerebral amyloid deposition in amyloid-beta precursor protein (APP) transgenic mice.
63 re we use Tg2576 mice, which express a human amyloid-beta precursor protein (APP) variant linked to A
64 ng synaptophysin, neurofilament H (NF-H) and amyloid-beta precursor protein (APP) were performed to e
65 n human and mouse leads to downregulation of amyloid-beta precursor protein (APP), a known neuronal m
66                                              Amyloid-beta precursor protein (APP), a type I membrane
67                                          The amyloid-beta precursor protein (APP), a type I transmemb
68                                              Amyloid-beta precursor protein (APP), a widely expressed
69 uce any change in the steady state levels of amyloid-beta precursor protein (APP), BACE1 or ADAM10.
70 oidogenic fragments (ie, C99 and Abeta) from amyloid-beta precursor protein (APP), crucial factors ca
71              Mutations in the genes encoding amyloid-beta precursor protein (APP), presenilin 1 (PS1)
72 P cleavage enzyme 1 (BACE1) that cleaves the amyloid-beta precursor protein (APP), which is abundant
73  peptides derived from the processing of the amyloid-beta precursor protein (APP).
74  4-kDa peptide generated via cleavage of the amyloid-beta precursor protein (APP).
75 s are neuronal adaptor proteins that bind to amyloid-beta precursor protein (APP).
76 s generated by proteolytic processing of the amyloid-beta precursor protein (APP).
77 nd in the brains of Alzheimer's patients and amyloid-beta precursor protein (APP)/PS1 transgenic mice
78 aneuronal accumulation of metabolites of the amyloid-beta-precursor protein (APP) is neurotoxic.
79 FAD has also been linked to mutations in the amyloid beta precursor protein (beta PP), and the presen
80                              The Alzheimer's amyloid-beta precursor protein (betaAPP) is a type 1 mem
81 ch is derived from proteolysis of the larger amyloid-beta precursor protein (betaAPP), seems to be an
82 pregulated in MDA-MB-231) and GREB1, S100A8, amyloid beta precursor protein, claudin 3 and cadherin 1
83 is required for intramembrane proteolysis of amyloid-beta precursor protein, contributing to the path
84 amyloid-beta precursor protein or C-terminal amyloid-beta precursor protein fragments.
85 disease, both caused by a duplication of the amyloid-beta precursor protein gene (APP; termed APP(Dp)
86 sport proteins JNK-interacting protein 1 and amyloid beta precursor protein in the brains and spinal
87              Binding of antithrombin and the amyloid beta-precursor protein Kunitz domain inhibitor (
88 siology of Alzheimer disease (AD), including amyloid-beta precursor protein metabolism, Tau phosphory
89 r order Abeta structures but not full-length amyloid-beta precursor protein or C-terminal amyloid-bet
90 , including transgenic mice expressing human amyloid-beta precursor protein, presenilin 1, and tau mu
91      Unexpectedly, C83, the major endogenous amyloid-beta precursor protein substrate of gamma-secret
92 f the Alzheimer's disease hallmark gene APP (amyloid-beta precursor protein) to the beta-site-cleavin
93 expression and secretase-cleaved products of amyloid-beta precursor protein were not affected by sucr
94  basic hypothesis is that over-expression of amyloid-beta precursor protein within aging muscle fiber

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。